Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preclinical Development of ADCT-601, a Novel Pyrrolobenzodiazepine Dimer-based Antibody-drug Conjugate Targeting AXL-expressing Cancers. | Mol Cancer Ther | 2022 | 35086955 | PubTator, text mining | PubMed |
| Identification of Novel Diagnostic Biomarkers in Prostate Adenocarcinoma Based on the Stromal-Immune Score and Analysis of the WGCNA and ceRNA Network. | Dis Markers | 2022 | 35075375 | PubTator, text mining | PubMed |
| Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma. | J Biomed Sci | 2022 | 35062934 | PubTator, text mining | PubMed |
| Biological Role of Vitamin K-With Particular Emphasis on Cardiovascular and Renal Aspects. | Nutrients | 2022 | 35057443 | PubTator, text mining | PubMed |
| Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma. | Int J Mol Sci | 2022 | 35055167 | PubTator, text mining | PubMed |
| Armed to the Teeth-The Oral Mucosa Immunity System and Microbiota. | Int J Mol Sci | 2022 | 35055069 | PubTator, text mining | PubMed |
| The Role of GRP and MGP in the Development of Non-Hemorrhagic VKCFD1 Phenotypes. | Int J Mol Sci | 2022 | 35054981 | PubTator, text mining | PubMed |
| The Impact of Vitamin K2 (Menaquionones) in Children's Health and Diseases: A Review of the Literature. | Children (Basel) | 2022 | 35053702 | PubTator, text mining | PubMed |
| The First Evaluation of Serum Levels of MGP, Gas6 and EGFR after First Dose of Chemotherapy in Lung Cancer. | Biology (Basel) | 2022 | 35053080 | PubTator, text mining | PubMed |
| A spatial and cellular distribution of rabies virus infection in the mouse brain revealed by fMOST and single-cell RNA sequencing. | Clin Transl Med | 2022 | 35051311 | PubTator, text mining | PubMed |
| Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications. | Cytokine Growth Factor Rev | 2022 | 35039221 | PubTator, text mining | PubMed |
| The role of phosphatidylserine on the membrane in immunity and blood coagulation. | Biomark Res | 2022 | 35033201 | PubTator, text mining | PubMed |
| Programmed death ligand 1 signals in cancer cells. | Nat Rev Cancer | 2022 | 35031777 | PubTator, text mining | PubMed |
| Identification of a regulatory pathway inhibiting adipogenesis via RSPO2. | Nat Metab | 2022 | 35027768 | PubTator, text mining | PubMed |
| Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer. | Signal Transduct Target Ther | 2022 | 35027529 | PubTator, text mining | PubMed |
| Neural regulations of the tumor microenvironment. | FASEB Bioadv | 2022 | 35024571 | PubTator, text mining | PubMed |
| Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration. | Mol Cancer Res | 2022 | 35022314 | PubTator, text mining | PubMed |
| Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. | Gut | 2022 | 35022267 | PubTator, text mining | PubMed |
| GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. | Cell | 2022 | 35021065 | PubTator, text mining | PubMed |
| Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. | Nat Rev Cancer | 2022 | 35013601 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=56